Tim Kelly Joins AskBio as President of Manufacturing to Lead AAV Vector Production for Gene Therapy
12 mars 2020 09h11 HE
|
Asklepios BioPharmaceutical, Inc.
RESEARCH TRIANGLE PARK, N.C., March 12, 2020 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today...